Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-07
1997-07-08
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540302, 5142228, C07D47706, C07D46300, A61K 31435, A61K 3140
Patent
active
056461399
ABSTRACT:
Compounds of Structure: ##STR1## as well as their pharmaceutically-acceptable salts and biohydrolyzable esters, and hydrates thereof, are effective antiinfective agents, useful in treating and preventing infection.
REFERENCES:
patent: 4146719 (1979-03-01), Irikura
patent: 4584132 (1986-04-01), Albrecht et al.
patent: 4599443 (1986-07-01), Chan et al.
patent: 4605744 (1986-08-01), Wei et al.
patent: 4620007 (1986-10-01), Grohe et al.
patent: 4631150 (1986-12-01), Battistini et al.
patent: 4642364 (1987-02-01), Chan et al.
patent: 4663469 (1987-05-01), Wei et al.
patent: 4670444 (1987-06-01), Grohe et al.
patent: 4692450 (1987-09-01), Cassal et al.
patent: 4742053 (1988-05-01), Nakagawa et al.
patent: 4801704 (1989-01-01), Keith et al.
patent: 4806541 (1989-02-01), Jolidon et al.
patent: 4831130 (1989-05-01), Albrecht et al.
patent: 4845087 (1989-07-01), Lattrell et al.
patent: 4845105 (1989-07-01), Clemence et al.
patent: 4874764 (1989-10-01), Ueda et al.
patent: 4900476 (1990-02-01), Chan et al.
patent: 4904478 (1990-02-01), Walsdorf et al.
patent: 4904647 (1990-02-01), Kulcsar et al.
patent: 4912214 (1990-03-01), Albrecht et al.
patent: 4927926 (1990-05-01), Corominas et al.
patent: 4954507 (1990-09-01), Weber et al.
patent: 5008259 (1991-04-01), Siret et al.
patent: 5013730 (1991-05-01), Arnould et al.
patent: 5013731 (1991-05-01), Arnould et al.
patent: 5039683 (1991-08-01), Nakanishi
patent: 5147871 (1992-09-01), Albrecht et al.
patent: 5159077 (1992-10-01), Keith et al.
patent: 5162523 (1992-11-01), Keith et al.
patent: 5180719 (1993-01-01), White et al.
patent: 5189157 (1993-02-01), Wei et al.
patent: 5273973 (1993-12-01), White et al.
patent: 5328908 (1994-07-01), Demuth et al.
patent: 5336768 (1994-08-01), Albrecht
Albrecht et al., "Dual-Action Cephalosporins: An Idea Whose Time Has Come", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy 186 (American Society for Microbiology, no month identified 1988).
Albrecht et al., "Dual-Action Cephalosporins: An Idea Whose Time Has Come", Poster Session: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 24, 1988).
Albrecht et al., "Dual-Action Cephalosporins: Cephalosporin-3'-Quaternary Quinolones", Program and Abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy (American Society for Microbiology, (no month identified 1989).
Albrecht, H.A., "Dual-Acton Cephalosporins Incorporating 3'-Tertiary Amine-Linked Quinolones", 31st Interscience Conference on Antibacterial Agents and Chemotherapy, Chicago, Illinois; Poster Session: Oct. 2, 1991 (Abs. & Poster).
Alpegiani, M. et al., "2-(Heteroatom-substituted)methyl Penems. IV. Oxygen Derivatives", Heterocycles, vol. 30, No. 2, pp. 799-812 (no month identified 1990).
Aries, R., "Acylated Aminopenicillins", Abstract #25655c, Heterocycles, vol. 81, p. 433 (no month identified 1974).
Aries, R., "Nalidixamido Cephems", Abstract #164210h, Heterocycles, vol. 83, p. 558 (no month identified 1975).
Bartkovitz, D. et al., "The Synthesis and Biological Properties of 2a-Methyl Substituted Penicillins", Abstract #824, 31st Interscience Conference on Antibacterial Agents and Chemotherapy (Chicago, Illinois), Oct. 1, 1991 (Abstract & Poster).
Beskid et al., "In Vitro Antibacterial Activity of Dual-Action Cephalosporin Ro 23-9424 and Comparative Agents", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy 187 (American Society for Microbiology, (no month identified 1988).
Beskid et al., "In Vivo Antibacterial Activity of Dual-Action Cephalosporin Ro 23-9424 Compared to Cefotaxime and Fleroxacin", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy 187 (American Society for Microbiology, (no month identified) 1988.
Beskid et al., "In Vitro Antibacterial Activity of Dual-Action Cephalosporin Ro 23-9424 and Comparative Agents", Poster Session: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 24, 1988).
Beskid et al., "In Vivo Antibacterial Activity of Dual-Action Cephalosporin Ro 23-9424 Compared to Cefotaxime and Fleroxacin", Poster Session: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 24, 1988).
Christenson et al., "Mode of Action of Ro 23-9424, a Dual-Action Cephalosporin", Poster Session: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 24, 1988).
Christenson et al., "Hydrolysis of Ro 23-9424 by .beta.-Lactamases", Poster Session: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 24, 1988).
Christenson et al., "Pharmakinetics of Ro 23-9424, a Dual-Action Cephalosporin, in Animals", Poster Session: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 24, 1988).
Christensen et al., "Pharmacokinetics of Ro 23-9424, a Dual-Action Cephalosporin In Animals", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy 188 (American Society for Microbiology, (no month indentified) 1988).
Christensen et al., "Hydrolysis of Ro 23-9424 by .beta.-Lactamases", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy 187 (American Society for Microbiology, (no month identified) 1988).
Christensen et al., "Mode of Action of Ro 23-9424, a Dual-Action Cephalosporin", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy 187 (American Society for Microbiology, (no month identified) 1988).
Christensen et al., "Mode of Action of Ro 23-5068, a Dual-Action Cephalosporin", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, 188 (American Society for Microbiology, (no month identified) 1988).
Christensen et al., "Mode of Action of Ro 23-5068, a Dual-Action Cephalosporin", Poster Session: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 24, 1988).
Cimarusti et al., "Monocyclic .beta.-Lactam Antibiotics", Medicinal Research Reviews, vol. 4, No. 1, pp. 1-24 (no month identified 1984).
Cleeland et al., "Dual-Action Antibacterials: A Concept Newly Recognized for Antibacterial Chemotherapy", Antimicrobic Newsletter, vol. 6, No. 8, pp. 61-68 (no month identified 1989).
Corraz, A.J. et al., "Dual-Action Penems and Carbapenems", Abstract #826, Poster #73, 31st Interscience Conference on Antibacterial Agents and Chemotherapy (Chicago, Illinois) Oct. 1, 1991 (Abstract & Poster).
Demuth, T.P., et al., "Synthesis and Antibacterial Activity of New C-10 Quinolonyl-Cephem Esters", The Journal of Antibiotics, vol. 44, No. 2, pp. 200-209 (Feb. 1991).
Durckheimer et al., "Recent Developments In The Field of .beta.-Lactam Antibiotics", Angew. Chem. Int. Ed. Engl., vol. 24, pp. 180-202 (no month identified 1985).
Fujimoto Pharmaceutical C., Ltd., "Penicillin Derivaties", Abstract #217590j, Chemical Abstracts, vol. 96, p. 718 (no month identified 1982).
Fujimoto Pharmaceutical C., Ltd., "Penicillin Derivaties", Abstract #55572w, Chemical Abstracts, vol. 97, p. 626 (no month identified 1982).
Fujimoto Pharmaceutical C., Ltd., "Cephalexin Derivaties", Abstract #72183n, Chemical Abstracts, vol. 96, p. 616 (no month identified 1982).
Georgopapadakou et al., "Cephalosporin-Quinolone Esters: Biological Properties", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy 186 (American Society for Microbiology, (no month identified) 1988).
Georgopapadakou et al., "Mode of Action of the Dual-Action Cephalosporin Ro 23-9424", Program and Abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy 187 (American Society for Microbiology, (no month identified) 1988).
Georgopapadakou et al., "Cephalosporin-Quinolone Esters: Biological Properties", Poster Session: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 24, 1988).
Georgopapadakou et al., "Mo
Demuth, Jr. Thomas Prosser
White Ronald Eugene
Clark Karen F.
Grumbling Matthew V.
Hake Richard A.
Suter David L.
The Procter & Gamble & Company
LandOfFree
Antimicrobial carbapenem quinolones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial carbapenem quinolones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial carbapenem quinolones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2408943